Browse drugs

… in leucopenia were slower, with no apparent difference between belimumab and placebo.Conclusion This post hoc analysis of data from five…

…nt platforms are interchangeable. This study compared RAPID and Brainomix CTP outputs in the same thrombectomy cohort.Methods We performe…

…poor. The PERICLES study explored a novel strategy of combining atezolizumab with radiation therapy for patients with advanced PeCa. 65 Howe…

…c neuropeptides, play a critical role in promoting wakefulness. Suvorexant, a dual orexin receptor antagonist, which is primarily indicate…

… ovarian cancer cells, independent of glycaemic status. Chronic insulin exposure remodels tumour cell phenotype through TGF-β/SMAD-depe…

…nts with CAC substantially improved clinician documentation and statin prescription rates. While larger studies should assess durabili…

… findings highlight the need for combination therapies, such as bempedoic acid, to optimize lipid management and achieve NICE targets in prima…

…Sclerosis (SSc) patients (Bruni et al. Eur J Intern Med. 2020). Macitentan, an orally active dual endothelin receptor antagonist, has been…

…ata and symptoms in SSe patients with or without treatment with hydroxychloroquine (HCQ)…

…r low knowledge (78.7%).Conclusions The opportunity to purchase HIVST in community pharmacies remains underutilised in Belgium. Enhan…

…otection afforded by three single-dose cardioplegic solutions — Custodiol (HTK), del Nido (DN) and modified del Nido (MDN) — in adult ele…

…mptom severity and breakthrough opioid or sedative use, whereas midazolam patients did not. Despite similar mild symptom scores and break…